Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen [PDF]
, 2002 The weakness in myasthenia gravis (MG) is mediated by autoantibodies against adult muscle acetylcholine receptors (AChR) at the neuromuscular junction; most of these antibodies also bind to fetal AChR, which is present in the thymus.
Wilcox, Nick +13 more
core +1 more source
Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study. [PDF]
Clin OphthalmolParinee Kemchoknatee,1 Boonravee Santitamrongvtit,2 Thansit Srisombut3 1Department of Ophthalmology, Rajavithi Hospital, Rangsit University, Bangkok, Thailand; 2Department of Medicine, Phra Nang Klao Hospital, Nonthaburi, Thailand; 3Department of ...
Kemchoknatee P +2 more
europepmc +2 more sources
Frontiers in Neurology, 2018 Bilateral cavernous carotid aneurysms (CCAs) represent a rare medical condition that can mimic other disorders. We present a rare case of bilateral CCAs simulating an ocular myasthenia.
Delia Gagliardi +12 more
doaj +1 more source
Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis
GMS Ophthalmology Cases, 2017 Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction. Ocular myasthenia gravis presents as ptosis with extraocular motility restriction and is prone to be misdiagnosed as third nerve palsy or congenital or aponeurotic ptosis ...
Alam, Md. Shahid, Devi Nivean, Pratheeba
doaj +1 more source
Diplopia in a patient presenting with “blurred vision”: a case report
Journal of Medical Case Reports, 2023 Background Myasthenia gravis is an autoimmune condition affecting the neuromuscular junction and causing muscle weakness along with fatigue (myasthenia).
Anil Harrison +3 more
doaj +1 more source
BMC Neurology, 2020 Background Ocular myasthenia gravis and Graves’ ophthalmopathy are autoimmune diseases that are mediated by membrane receptors and share many identical clinical processes.
Jingqun Tang, Chao Qin
doaj +1 more source
Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report
American Journal of Ophthalmology Case Reports, 2022 Purpose: We report on the case of a 35-year-old man who developed myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccine injection. Observations: A 35-year-old man complained of binocular diplopia one month following ChAdOx1 nCoV-19 ...
Min Chae Kang +3 more
doaj +1 more source
Pediatric ocular myasthenia gravis: Case report and literature review
The Pan-American Journal of Ophthalmology, 2019 Objective: The objective was to describe a case of ocular myasthenia gravis (MG) in a pediatric patient. Design: This is a descriptive, retrospective study and case report.
Adriana Solano +3 more
doaj +1 more source
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
Annals of Clinical and Translational Neurology, 2020 Objective To assess whether eculizumab, a terminal complement inhibitor, improves patient‐ and physician‐reported outcomes (evaluated using the myasthenia gravis activities of daily living profile and the quantitative myasthenia gravis scale ...
Renato Mantegazza +4 more
doaj +1 more source
The Effect of Acupuncture on Blepharoptosis and Diplopia in Ocular Myasthenia Gravis: A Report of Three Cases [PDF]
Patient Safety and Quality Improvement Journal, 2015 Introduction: The aim of this study was to evaluate the efficacy of acupuncture therapy on relieving ocular symptoms in resistant Ocular Myasthenia Gravis (OMG).
Mohammad Etezad Razavi +3 more
doaj